May 3, 2021

Via EDGAR
 
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
 

Re:
Chembio Diagnostics, Inc.
Registration Statement on Form S-3
Filed March 15, 2021
File No. 333-254261
Request for Acceleration

Ladies and Gentlemen:
 
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Chembio Diagnostics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-254261) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern time on May 5, 2021, or as soon thereafter as practicable.
 
Please do not hesitate to contact our legal counsel, Mark L. Johnson, at (617) 261-3260, if you have any questions or would like additional information regarding this matter.
 
*   *   *

 
Sincerely,
   
 
Chembio Diagnostics, Inc.
     
 
By:
/s/Neil A. Goldman
 
   
Neil A. Goldman
   
Executive Vice President, Chief Financial Officer
 
cc:
Mark L. Johnson, K&L Gates LLP
Bella Zaslavsky, K&L Gates LLP